In clinical practice, peripheral lung cancer with mediastinal lymph node metastasis is an advanced symptom of cancer and is generally difficult to cure. The survival rate and survival time are also related to each individual’s own qualities, including physical and psychological aspects, as well as to their own care and the overall treatment process. The location and number of mediastinal lymph node metastases in peripheral lung cancer also determine the specific treatment modality and direction of the patient.
The treatment of patients with mediastinal lymph node metastases from peripheral lung cancer is generally related to the clinical stage. In general, if patients with lymphatic metastases have obvious limitations, such as mediastinal lymph node metastases and ipsilateral hilum, they are mostly treated clinically with surgery. In the case of significant contralateral or supraclavicular lymph node metastases, treatment by radiotherapy is required.
Patients should first actively cooperate with their doctors in the treatment process and adjust their emotional and psychological state. It is easy to lose one’s immunity during radiotherapy, so it is important to strengthen the intake of nutrients, actively and correctly face the disease, and actively treat it, both to prolong survival and to improve the prognosis.